GlassScriptPhysician profile
Patrick Joseph Keehan
NPI 1366773889
$712,536.14
in general payments reported to CMS, 2019-2025
49 companies · $159K in 2025
The $159K reported for 2025 was more than what 98% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146K · 2020: $32K · 2021: $54K · 2022: $73K · 2023: $95K · 2024: $154K · 2025: $159K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $339K · Food and Beverage: $25K · Consulting Fee: $23K · Travel and Lodging: $16K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,971 · Education: $290 · Honoraria: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $339,298.58 |
| Food and Beverage | $25,372.86 |
| Consulting Fee | $22,590.73 |
| Travel and Lodging | $16,064.04 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,971.00 |
| Education | $289.79 |
| Honoraria | $260.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $232,986.95 | 2019-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $160,088.91 | 2019-2025 | |
| Janssen Biotech, INC. | $71,441.73 | 2019-2025 | Tremfya, Simponi, Stelara |
| Galderma Laboratories, L.P. | $64,915.65 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Arcutis Biotherapeutics, INC. | $26,752.99 | 2023-2025 | Zoryve |
| Genzyme Corporation | $24,210.44 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $23,819.99 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $23,794.54 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $22,421.41 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $16,367.82 | 2019-2025 | Ilumya, Blu-U, Odomzo |
| Genentech USA, INC. | $15,230.18 | 2019-2025 | Xolair |
| Pfizer INC. | $7,544.42 | 2019-2025 | |
| Dusa Pharmaceuticals, INC. | $7,188.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $2,139.49 | 2021-2025 | Sotyktu |
| Leo Pharma INC. | $1,897.46 | 2019-2025 | Adbry, Anzupgo |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,485.64 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $1,406.32 | 2022-2025 | Opzelura, Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,255.83 | 2019-2025 | Cabtreo, Siliq, Targretin |
| Journey Medical Corporation | $1,227.86 | 2019-2025 | |
| Dermavant Sciences, INC. | $1,168.86 | 2022-2024 | Vtama |
| Amgen INC. | $915.07 | 2019-2025 | Otezla, Otezla |
| Mayne Pharma Commercial LLC | $897.57 | 2019-2025 | |
| Medimetriks Pharmaceuticals, INC. | $672.75 | 2019-2025 | Neo-Synalar |
| Almirall LLC | $617.06 | 2019-2025 | Klisyri, Seysara |
| Biofrontera INC. | $347.37 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Paratek Pharmaceuticals, INC. | $202.21 | 2021-2025 | Nuzyra |
| Vyne Pharmaceuticals INC. | $171.69 | 2020 | |
| Organon LLC | $161.93 | 2025 | Vtama |
| Strata Skin Sciences, INC. | $159.43 | 2020-2025 | Xtrac |
| Sanofi US Services INC. | $122.74 | 2025 | |
| Verrica Pharmaceuticals INC. | $98.39 | 2023 | Ycanth |
| Sanofi-Aventis U.S. LLC | $94.99 | 2024 | |
| Sandoz INC. | $92.39 | 2019-2023 | Hyrimoz |
| Kyowa Kirin, INC. | $91.60 | 2024 | Poteligeo |
| Encore Dermatology INC. | $88.85 | 2019 | |
| Dermira, INC. | $75.70 | 2019-2020 | |
| Celgene Corporation | $63.19 | 2019 | |
| Botanix Sb INC | $52.45 | 2025 | Sofdra |
| Aclaris Therapeutics, INC. | $41.65 | 2019 | |
| Tactile Systems Technology INC | $40.45 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.31 | 2022 | |
| Springworks Therapeutics, INC. | $23.38 | 2025 | Gomekli |
| Otsuka America Pharmaceutical, INC. | $22.09 | 2024 | Jynarque |
| Promius Pharma LLC | $20.77 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $20.32 | 2019 | |
| Chiesi USA, INC. | $19.23 | 2024 | Filsuvez |
| Epi Health, LLC | $17.66 | 2019 | |
| Medtronic Vascular, INC. | $14.45 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Keehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.